---
title: "IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile  Idiopathic Arthritis."
date: 2018-08-01
publishDate: 2020-08-03T19:38:06.677952Z
authors: ["Victoria L. Arthur", "Emily Shuldiner", "Elaine F. Remmers", "Anne Hinks", "Alexei A. Grom", "Dirk Foell", "Alberto Martini", "Marco Gattorno", "Seza Ozen", "Sampath Prahalad", "Andrew S. Zeft", "John F. Bohnsack", "Norman T. Ilowite", "Elizabeth D. Mellins", "Ricardo Russo", "Claudio Len", "Sheila Oliveira", "Rae S. M. Yeung", "Alan M. Rosenberg", "Lucy R. Wedderburn", "Jordi Anton", "Johannes-Peter Haas", "Angela Rosen-Wolff", "Kirsten Minden", "Ann Marie Szymanski", "Wendy Thomson", "Daniel L. Kastner", "Patricia Woo", "Michael J. Ombrello"]
publication_types: ["2"]
abstract: "OBJECTIVE: To determine whether systemic juvenile idiopathic arthritis (JIA) susceptibility loci that were identified by candidate gene studies demonstrate association with systemic JIA in the largest study population assembled to date.  METHODS: Single-nucleotide polymorphisms (SNPs) from 11 previously reported systemic JIA risk loci were examined for association in 9 populations, including  770 patients with systemic JIA and 6,947 controls. The effect of systemic"
featured: false
publication: "*Arthritis & rheumatology (Hoboken, N.J.)*"
tags: ["Female", "Humans", "Male", "Child", "Case-Control Studies", "Genome-Wide Association Study", "Alleles", "Odds Ratio", "Genetic Predisposition to Disease/*genetics", "Antirheumatic Agents/*pharmacology", "Arthritis", "Juvenile/drug therapy/*genetics", "Interleukin 1 Receptor Antagonist Protein/drug effects/genetics/*pharmacology", "Pharmacogenomic Variants/drug effects/genetics", "Polymorphism", "Single Nucleotide/drug effects/genetics", "Promoter Regions", "Genetic/genetics"]
doi: "10.1002/art.40498"
---

